CAPITAL MANAGEMENT OSS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CAPITAL MANAGEMENT OSS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CAPITAL MANAGEMENT OSS. CAPITAL MANAGEMENT OSS is 10% Owner in NOVEN PHARMACEUTICALS INC ($NOVN) and 10% Owner in TESCO CORP ($TESOF) and 10% Owner in ULURU Inc. ($OXFV) and 10% Owner in BOULDER BRANDS, INC. ($BSBR).
Latest Insider Trading Transactions of CAPITAL MANAGEMENT OSS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BSBR, NOVN, TESOF, OXFV
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2010 | OXFV | ULURU Inc. | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 0.16 | 3,400,000 | 544,000 | 8,061,522 | 11.5 M to 8.1 M (-29.66 %) |
Apr 05 2010 | OXFV | ULURU Inc. | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 0.17 | 57,550 | 9,784 | 11,461,522 | 11.5 M to 11.5 M (-0.50 %) |
Apr 02 2010 | OXFV | ULURU Inc. | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 0.17 | 30,620 | 5,205 | 11,519,072 | 11.5 M to 11.5 M (-0.27 %) |
Apr 02 2010 | OXFV | ULURU Inc. | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 0.17 | 137,723 | 23,413 | 11,549,692 | 11.7 M to 11.5 M (-1.18 %) |
Mar 12 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 9.00 | 11,324 | 101,916 | 2,486,444 | 2.5 M to 2.5 M (-0.45 %) |
Mar 06 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 9.34 | 1,100 | 10,274 | 2,497,768 | 2.5 M to 2.5 M (-0.04 %) |
Mar 06 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 9.02 | 232,000 | 2,092,640 | 2,498,868 | 2.7 M to 2.5 M (-8.50 %) |
Mar 04 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 9.65 | 529 | 5,105 | 2,730,868 | 2.7 M to 2.7 M (-0.02 %) |
Feb 23 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 9.65 | 5,398 | 52,091 | 2,731,397 | 2.7 M to 2.7 M (-0.20 %) |
Feb 23 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 9.65 | 7,000 | 67,550 | 2,736,795 | 2.7 M to 2.7 M (-0.26 %) |
Feb 19 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 9.65 | 10,000 | 96,500 | 2,743,795 | 2.8 M to 2.7 M (-0.36 %) |
Feb 19 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 9.68 | 17,000 | 164,560 | 2,753,795 | 2.8 M to 2.8 M (-0.61 %) |
Feb 17 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 9.91 | 21,561 | 213,670 | 2,770,795 | 2.8 M to 2.8 M (-0.77 %) |
Feb 17 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 10.01 | 14,140 | 141,541 | 2,792,356 | 2.8 M to 2.8 M (-0.50 %) |
Feb 02 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 9.98 | 25,000 | 249,500 | 2,806,496 | 2.8 M to 2.8 M (-0.88 %) |
Feb 02 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 10.10 | 25,000 | 252,500 | 2,831,496 | 2.9 M to 2.8 M (-0.88 %) |
Jan 21 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 11.00 | 100,000 | 1,100,000 | 2,956,496 | 3.1 M to 3 M (-3.27 %) |
Jan 29 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 10.55 | 50,000 | 527,500 | 2,856,496 | 2.9 M to 2.9 M (-1.72 %) |
Jan 29 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 10.32 | 50,000 | 516,000 | 2,906,496 | 3 M to 2.9 M (-1.69 %) |
Jan 13 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 11.00 | 7,989 | 87,879 | 3,056,496 | 3.1 M to 3.1 M (-0.26 %) |
Jan 09 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 11.09 | 29,039 | 322,043 | 3,064,485 | 3.1 M to 3.1 M (-0.94 %) |
Jan 09 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 11.16 | 50,000 | 558,000 | 3,093,524 | 3.1 M to 3.1 M (-1.59 %) |
Jan 07 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 11.05 | 50,000 | 552,500 | 3,143,524 | 3.2 M to 3.1 M (-1.57 %) |
Jan 07 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 11.01 | 66,290 | 729,853 | 3,193,524 | 3.3 M to 3.2 M (-2.03 %) |
Jan 05 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 11.02 | 34,621 | 381,523 | 3,259,814 | 3.3 M to 3.3 M (-1.05 %) |
Jan 05 2009 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 11.00 | 74,409 | 818,499 | 3,294,435 | 3.4 M to 3.3 M (-2.21 %) |
Nov 10 2008 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 7.06 | 230,000 | 1,623,800 | 6,052,270 | 6.3 M to 6.1 M (-3.66 %) |
Oct 08 2008 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 5.99 | 200,000 | 1,198,000 | 6,282,270 | 6.5 M to 6.3 M (-3.09 %) |
Dec 29 2008 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 11.00 | 1,255 | 13,805 | 3,368,911 | 3.4 M to 3.4 M (-0.04 %) |
Dec 29 2008 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 11.00 | 9,503 | 104,533 | 3,370,166 | 3.4 M to 3.4 M (-0.28 %) |
Dec 29 2008 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 11.00 | 38,735 | 426,085 | 3,379,669 | 3.4 M to 3.4 M (-1.13 %) |
Oct 31 2008 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 10.65 | 6,286 | 66,946 | 3,418,404 | 3.4 M to 3.4 M (-0.18 %) |
Feb 14 2008 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 8.40 | 50,000 | 420,000 | 6,090,770 | 6 M to 6.1 M (+0.83 %) |
Feb 01 2008 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 12.05 | 50,000 | 602,500 | 4,000,770 | 4 M to 4 M (+1.27 %) |
Feb 01 2008 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 9.50 | 90,000 | 855,000 | 2,195,000 | 2.1 M to 2.2 M (+4.28 %) |
Feb 01 2008 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 9.49 | 10,000 | 94,900 | 2,105,000 | 2.1 M to 2.1 M (+0.48 %) |
Jan 08 2008 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 9.80 | 30,000 | 294,000 | 5,890,770 | 5.9 M to 5.9 M (+0.51 %) |
Jan 07 2008 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 10.24 | 25,000 | 256,000 | 5,860,770 | 5.8 M to 5.9 M (+0.43 %) |
Mar 31 2008 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 9.73 | 118,000 | 1,148,140 | 3,424,690 | 3.3 M to 3.4 M (+3.57 %) |
Mar 17 2008 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 10.92 | 100,000 | 1,092,000 | 3,306,690 | 3.2 M to 3.3 M (+3.12 %) |
Nov 14 2007 | OXFV | ULURU Inc. | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 3.02 | 11,100 | 33,522 | 11,687,415 | 11.7 M to 11.7 M (+0.10 %) |
Dec 26 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 11.26 | 15,000 | 168,900 | 5,835,770 | 5.8 M to 5.8 M (+0.26 %) |
Dec 21 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 11.23 | 25,000 | 280,750 | 5,820,770 | 5.8 M to 5.8 M (+0.43 %) |
Dec 06 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Option Exercise | X | 6.00 | 1,875,000 | 11,250,000 | 0 | |
Dec 06 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | X | 6.00 | 1,875,000 | 11,250,000 | 5,795,770 | 3.9 M to 5.8 M (+47.82 %) |
Nov 13 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 11.28 | 35,000 | 394,800 | 3,885,770 | 3.9 M to 3.9 M (+0.91 %) |
Nov 14 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 11.52 | 35,000 | 403,200 | 3,920,770 | 3.9 M to 3.9 M (+0.90 %) |
Oct 18 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 11.84 | 40,000 | 473,600 | 3,850,770 | 3.8 M to 3.9 M (+1.05 %) |
Oct 17 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 11.68 | 60,000 | 700,800 | 3,810,770 | 3.8 M to 3.8 M (+1.60 %) |
Oct 16 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 11.81 | 27,700 | 327,137 | 3,750,770 | 3.7 M to 3.8 M (+0.74 %) |
Oct 15 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 12.25 | 40,000 | 490,000 | 3,723,070 | 3.7 M to 3.7 M (+1.09 %) |
Oct 11 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 12.57 | 15,000 | 188,550 | 3,683,070 | 3.7 M to 3.7 M (+0.41 %) |
Oct 02 2007 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 16.05 | 310,000 | 4,975,500 | 3,206,690 | 2.9 M to 3.2 M (+10.70 %) |
Sep 27 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 11.55 | 36,000 | 415,800 | 3,528,070 | 3.5 M to 3.5 M (+1.03 %) |
Sep 11 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 11.01 | 102,550 | 1,129,076 | 3,492,070 | 3.4 M to 3.5 M (+3.03 %) |
Sep 11 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 10.63 | 500,000 | 5,315,000 | 3,389,520 | 2.9 M to 3.4 M (+17.30 %) |
Sep 07 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 10.25 | 500,000 | 5,125,000 | 2,889,520 | 2.4 M to 2.9 M (+20.92 %) |
Sep 07 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 9.50 | 150,000 | 1,425,000 | 2,389,520 | 2.2 M to 2.4 M (+6.70 %) |
Sep 07 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 9.45 | 144,520 | 1,365,714 | 2,239,520 | 2.1 M to 2.2 M (+6.90 %) |
Sep 07 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 9.50 | 25,000 | 237,500 | 2,095,000 | 2.1 M to 2.1 M (+1.21 %) |
Sep 07 2007 | BSBR | BOULDER BRANDS, IN ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 9.00 | 25,000 | 225,000 | 2,070,000 | 2 M to 2.1 M (+1.22 %) |
Sep 17 2007 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 16.47 | 35,000 | 576,450 | 2,896,690 | 2.9 M to 2.9 M (+1.22 %) |
Sep 12 2007 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 15.48 | 77,500 | 1,199,700 | 2,784,190 | 2.7 M to 2.8 M (+2.86 %) |
Aug 08 2007 | NOVN | NOVEN PHARMACEUTIC ... | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 16.20 | 80,000 | 1,296,000 | 2,691,690 | 2.6 M to 2.7 M (+3.06 %) |
Jun 12 2007 | OXFV | ULURU Inc. | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 4.89 | 1,000,000 | 4,890,000 | 11,676,315 | 10.7 M to 11.7 M (+9.37 %) |
Apr 16 2007 | OXFV | ULURU Inc. | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 4.92 | 50,000 | 246,000 | 10,676,315 | 10.6 M to 10.7 M (+0.47 %) |
Apr 04 2007 | OXFV | ULURU Inc. | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 4.97 | 100,000 | 497,000 | 10,626,315 | 10.5 M to 10.6 M (+0.95 %) |
Nov 21 2005 | TESOF | TESCO CORP | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 17.89 | 9,200 | 164,588 | 4,000,000 | 4 M to 4 M (+0.23 %) |
Nov 16 2005 | TESOF | TESCO CORP | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 16.08 | 42,600 | 685,008 | 3,644,600 | 3.6 M to 3.6 M (+1.18 %) |
Nov 18 2005 | TESOF | TESCO CORP | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 17.54 | 146,000 | 2,560,840 | 3,990,800 | 3.8 M to 4 M (+3.80 %) |
Nov 17 2005 | TESOF | TESCO CORP | OSS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 16.89 | 200,200 | 3,381,378 | 3,844,800 | 3.6 M to 3.8 M (+5.49 %) |
Page: 1